BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CML.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples